skin neoplasms

Ipilimumab plus nivolumab in avelumab-refractory Merkel cell carcinoma: a multicenter study of the prospective skin cancer registry ADOREG
Valerie Glutsch, Patrick Schummer, Hermann Kneitz, Anja Gesierich, Matthias Goebeler, Detlef Klein, Christian Posch, Christoffer Gebhardt, Sebastian Haferkamp, Lisa Zimmer, Jürgen C Becker, Ulrike Leiter, Michael Weichenthal, Dirk Schadendorf, Selma Ugurel, Bastian Schilling

Journal for ImmunoTherapy of Cancer Nov 2022, 10 (11) e005930; DOI: 10.1136/jitc-2022-005930
Transcriptional and functional analyses of neoantigen-specific CD4 T cells during a profound response to anti-PD-L1 in metastatic Merkel cell carcinoma
Candice Church, Thomas Pulliam, Natalie Longino, Song Y Park, Kimberly S Smythe, Vladimir Makarov, Nadeem Riaz, Lichen Jing, Robert Amezquita, Jean S Campbell, Raphael Gottardo, Robert H Pierce, Jaehyuk Choi, Timothy A Chan, David M Koelle, Paul Nghiem

Journal for ImmunoTherapy of Cancer Sep 2022, 10 (9) e005328; DOI: 10.1136/jitc-2022-005328
Real-world clinical outcomes with avelumab in patients with Merkel cell carcinoma treated in the USA: a multicenter chart review study
Shailender Bhatia, Paul Nghiem, S Phani Veeranki, Alejandro Vanegas, Kristina Lachance, Lisa Tachiki, Kevin Chiu, Emily Boller, Murtuza Bharmal

Journal for ImmunoTherapy of Cancer Aug 2022, 10 (8) e004904; DOI: 10.1136/jitc-2022-004904
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of nonmelanoma skin cancer
Ann W Silk, Christopher A Barker, Shailender Bhatia, Kathryn B Bollin, Sunandana Chandra, Zeynep Eroglu, Brian R Gastman, Kari L Kendra, Harriet Kluger, Evan J Lipson, Kathleen Madden, David M Miller, Paul Nghiem, Anna C Pavlick, Igor Puzanov, Guilherme Rabinowits, Emily S Ruiz, Vernon K Sondak, Edward A Tavss, Michael T Tetzlaff, Isaac Brownell

Journal for ImmunoTherapy of Cancer Jul 2022, 10 (7) e004434; DOI: 10.1136/jitc-2021-004434
Nationwide multidisciplinary consensus on the clinical management of Merkel cell carcinoma: a Delphi panel
Francesca Spada, Paolo Bossi, Corrado Caracò, Vanna Chiarion Sileni, Angelo Paolo Dei Tos, Nicola Fazio, Giovanni Grignani, Michele Maio, Pietro Quaglino, Paola Queirolo, Paolo Antonio Ascierto

Journal for ImmunoTherapy of Cancer Jun 2022, 10 (6) e004742; DOI: 10.1136/jitc-2022-004742
Clinical activity of PD-1 inhibition in the treatment of locally advanced or metastatic basal cell carcinoma
Gino Kim In, Aparna Nallagangula, Jacob Seung Choi, Lisa Tachiki, Matthew J Blackburn, Stephen Capone, Kathryn B Bollin, Daniel Y. Reuben, Keisuke Shirai, Sandy Zhang-Nunes, Omar Ragab, Alicia Terando, Jenny C. Hu, Han Lee, Shailender Bhatia, Sunandana Chandra, Jose Lutzky, Geoffrey Thomas Gibney

Journal for ImmunoTherapy of Cancer May 2022, 10 (5) e004839; DOI: 10.1136/jitc-2022-004839
Clinical and molecular characteristics associated with response to therapeutic PD-1/PD-L1 inhibition in advanced Merkel cell carcinoma
Ivelina Spassova, Selma Ugurel, Linda Kubat, Lisa Zimmer, Patrick Terheyden, Annalena Mohr, Hannah Björn Andtback, Lisa Villabona, Ulrike Leiter, Thomas Eigentler, Carmen Loquai, Jessica C Hassel, Thilo Gambichler, Sebastian Haferkamp, Peter Mohr, Claudia Pfoehler, Lucie Heinzerling, Ralf Gutzmer, Jochen S Utikal, Kai Horny, Hans-Ulrich Schildhaus, Daniel Habermann, Daniel Hoffmann, Dirk Schadendorf, Jürgen Christian Becker

Journal for ImmunoTherapy of Cancer Jan 2022, 10 (1) e003198; DOI: 10.1136/jitc-2021-003198
Leveraging immune memory against measles virus as an antitumor strategy in a preclinical model of aggressive squamous cell carcinoma
Victoria M Leb-Reichl, Melanie Kienzl, Anna Kaufmann, Angelika Stoecklinger, Birgit Tockner, Sophie Kitzmueller, Nadja Zaborsky, Markus Steiner, Gabriele Brachtl, Lisa Trattner, Patrick Kreideweiss, Christian Reinsch, Steffen Panzner, Richard Greil, Dirk Strunk, Johann W Bauer, Iris K Gratz, Christina Guttmann-Gruber, Josefina Piñón Hofbauer

Journal for ImmunoTherapy of Cancer Oct 2021, 9 (10) e002170; DOI: 10.1136/jitc-2020-002170
Integrated analysis of a phase 2 study of cemiplimab in advanced cutaneous squamous cell carcinoma: extended follow-up of outcomes and quality of life analysis
Danny Rischin, Nikhil I Khushalani, Chrysalyne D Schmults, Alexander Guminski, Anne Lynn S Chang, Karl D Lewis, Annette M Lim, Leonel Hernandez-Aya, Brett G M Hughes, Dirk Schadendorf, Axel Hauschild, Alesha A Thai, Elizabeth Stankevich, Jocelyn Booth, Suk-Young Yoo, Siyu Li, Zhen Chen, Emmanuel Okoye, Chieh-I Chen, Vera Mastey, Medha Sasane, Israel Lowy, Matthew G Fury, Michael R Migden

Journal for ImmunoTherapy of Cancer Aug 2021, 9 (8) e002757; DOI: 10.1136/jitc-2021-002757
First-line avelumab in a cohort of 116 patients with metastatic Merkel cell carcinoma (JAVELIN Merkel 200): primary and biomarker analyses of a phase II study
Sandra P D'Angelo, Celeste Lebbé, Laurent Mortier, Andrew S Brohl, Nicola Fazio, Jean-Jacques Grob, Natalie Prinzi, Glenn J Hanna, Jessica C Hassel, Felix Kiecker, Sara Georges, Barbara Ellers-Lenz, Parantu Shah, Gülseren Güzel, Paul Nghiem

Journal for ImmunoTherapy of Cancer Jul 2021, 9 (7) e002646; DOI: 10.1136/jitc-2021-002646

Main menu

skin neoplasms

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

skin neoplasms

Pages